A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.

about

Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.Metformin: An Old Drug with New Applications

P2860

Q54528195-5E15E3C1-C7D6-4AC2-98D3-F8EAD1820E32 Q59138339-0F40ACB6-271F-4F6D-A94A-9E68099D0FD1

P2860

A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.

Item

http://www.wikidata.org/entity/Q39044686

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@en

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@nl

type

Item

label

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@en

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@nl

prefLabel

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@en

A Combination of Leucine, Metf ...... e and Steatohepatitis in Mice.

@nl

P1476

A Combination of Leucine, Metf ...... se and Steatohepatitis in Mice

@en

P2093

Fenfen Li

http://www.w3.org/2001/XMLSchema#string

Hang Shi

http://www.w3.org/2001/XMLSchema#string

Lizhi Fu

http://www.w3.org/2001/XMLSchema#string

Qiang Cao

http://www.w3.org/2001/XMLSchema#string

Rui Wu

http://www.w3.org/2001/XMLSchema#string

Xin Cui

http://www.w3.org/2001/XMLSchema#string

P2860

AMPK and PPARdelta agonists are exercise mimetics

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and Inflame

The pleiotropic effects of phosphodiesterase 5 inhibitors on function and safety in patients with cardiovascular disease and hypertension

Nitric oxide synthases: regulation and function

The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease

Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling.

Reduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF rats

P304

9185987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/9185987

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28042486

http://www.w3.org/2001/XMLSchema#string

P921

metformin

Steatohepatitis

P932

5155097

http://www.w3.org/2001/XMLSchema#string

A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.

about

P2860

P2860

A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P921

P932